dromedari
camel
shown
main
reservoir
human
middl
east
respiratori
syndrom
mer
infect
systemat
review
aim
compil
analys
publish
data
merscoronaviru
cov
global
camel
popul
provid
overview
current
knowledg
distribut
spread
risk
factor
infect
dromedari
camel
includ
origin
research
articl
contain
laboratori
evid
merscov
infect
dromedari
camel
field
april
gener
camel
show
minor
clinic
sign
diseas
infect
merscov
serolog
evid
merscov
camel
found
countri
molecular
evid
viru
circul
countri
seropreval
merscov
antibodi
increas
age
camel
preval
viral
shed
determin
merscov
rna
detect
nasal
swab
decreas
sever
studi
camel
sampl
anim
market
quarantin
facil
seroposit
often
camel
farm
well
import
camel
vs
local
bred
camel
studi
show
rel
higher
seropreval
viral
detect
cooler
winter
month
knowledg
anim
reservoir
merscov
essenti
develop
intervent
control
measur
prevent
human
infect
middl
east
respiratori
syndrom
mer
highli
fatal
respiratori
tract
diseas
human
first
detect
kingdom
saudi
arabia
ksa
first
detect
merscoronaviru
merscov
report
human
patient
across
arabian
peninsula
occasion
travelrel
case
contin
end
march
total
human
laboratoryconfirm
case
countri
report
world
health
organis
includ
associ
death
dromedari
camel
camelu
dromedari
shown
natur
reservoir
spillov
human
occur
humantohuman
infect
also
report
frequent
especi
healthcar
set
sustain
humantohuman
transmiss
outsid
hospit
set
shown
yet
direct
indirect
human
contact
camel
result
repeat
introduct
merscov
human
popul
suggest
camel
may
acquir
merscov
spillov
event
bat
reservoir
evid
remain
inconclus
infect
merscov
gener
thought
mild
inappar
camel
therefor
low
econom
anim
welfar
signific
systemat
review
done
compil
analys
publish
data
merscov
global
camel
popul
provid
overview
current
knowledg
distribut
spread
risk
factor
merscov
infect
dromedari
camel
basi
design
intervent
control
measur
prevent
human
infect
may
literatur
search
pubm
perform
use
term
middl
east
respiratori
syndrom
coronaviru
merscov
use
term
mer
result
addit
articl
fit
scope
review
articl
publish
english
includ
two
review
individu
select
origin
research
articl
contain
laboratori
evid
merscov
infect
dromedari
camel
field
articl
mention
food
agricultur
organ
fao
updat
refer
includ
public
appear
pubm
search
ad
subsequ
abstract
followup
studi
merscovposit
camel
genom
studi
without
preval
data
exclud
analysi
data
variabl
year
sampl
countri
region
age
sex
anim
origin
extract
analys
variabl
number
posit
camel
total
number
camel
test
median
percentag
posit
calcul
data
experiment
infect
studi
includ
analysi
includ
review
provid
addit
inform
context
field
studi
addit
inform
distribut
trade
dromedari
camel
collect
refer
public
merscov
camel
extract
offici
fao
world
organis
anim
health
oie
databas
addit
literatur
camel
trade
collect
less
systemat
way
pubm
literatur
search
result
total
paper
fig
fortythre
research
paper
describ
result
crosssect
studi
dromedari
camel
popul
six
paper
describ
outbreak
investig
includ
analysi
camel
sampl
four
paper
describ
longitudin
studi
total
paper
describ
camel
studi
middl
east
studi
investig
camel
africa
remain
seven
survey
spain
australia
japan
bangladesh
pakistan
tabl
recent
fao
statist
estim
world
popul
camel
around
million
approxim
dromedari
camel
howev
believ
true
popul
size
even
larger
due
inaccur
statist
feral
camel
feral
dromedari
camel
popul
australia
estim
around
million
camel
popul
live
africa
main
camel
countri
chad
ethiopia
kenya
mali
mauritania
niger
sudan
somalia
pakistan
tabl
larg
number
camel
transport
horn
africa
middl
east
year
mainli
meat
camel
come
east
africa
go
egypt
libya
gulf
state
sudanes
camel
import
middl
east
particip
camel
race
competit
exampl
fao
report
somalia
export
camel
largest
camel
market
africa
birqash
market
near
cairo
egypt
camel
sudan
ethiopia
common
trade
rout
includ
anim
chad
somalia
eritrea
kenya
import
camel
usual
quarantin
day
border
allow
enter
egypt
somali
sudanes
camel
export
ksa
ship
port
berbera
bosaso
north
somalia
ksa
port
jizan
jeddah
gener
minor
clinic
sign
diseas
observ
anim
infect
merscov
merscov
infect
appear
caus
symptom
diseas
symptom
describ
experiment
field
infect
cough
sneez
respiratori
discharg
fever
loss
appetit
although
merscov
rna
detect
sever
organ
experiment
infect
studi
natur
infecti
viru
detect
tissu
upper
lower
respiratori
tract
region
lymph
node
respiratori
system
part
infect
camel
histolog
mildtomoder
inflamm
necrosi
could
also
seen
upper
lower
respiratori
tract
viral
antigen
lesion
detect
alveoli
histopatholog
examin
show
nasal
respiratori
epithelium
princip
site
merscov
replic
camel
one
studi
investig
experiment
infect
camel
merscov
shed
start
day
postinfect
dpi
studi
infecti
viru
could
detect
dpi
viral
rna
dpi
nasal
swab
sampl
lower
amount
oral
swab
sampl
infecti
viru
viral
rna
detect
faecal
urin
sampl
viral
rna
detect
nasal
also
rectal
swab
camel
experiment
infect
day
confirm
recent
vaccin
studi
field
survey
includ
review
merscov
rna
describ
rectal
swab
sampl
although
field
studi
report
neg
result
viral
rna
detect
posit
rate
rectal
swab
lower
compar
nasal
swab
sampl
oral
swab
usual
neg
show
lower
posit
rate
even
nasal
swab
test
posit
merscov
rna
studi
report
merscov
rna
milk
sampl
longitudin
studi
camel
herd
show
pcr
result
nasal
swab
remain
posit
week
interv
sampl
month
maintain
nasal
swab
becom
neg
viral
rna
next
sampl
round
merscov
infect
also
detect
camel
merscov
antibodi
calv
matern
antibodi
well
older
camel
alreadi
acquir
antibodi
previou
infect
howev
viru
replic
thu
viru
load
gener
lower
infect
seroposit
anim
compar
seroneg
camel
littl
known
longev
antibodi
titr
infect
longitudin
studi
studi
follow
camel
close
farm
found
neutral
antibodi
remain
consist
year
studi
found
antibodi
titr
rapidli
drop
within
period
often
short
week
first
evid
merscov
camel
describ
far
detect
antibodi
merscov
camel
sera
somalia
sudan
test
posit
addit
serolog
evid
widespread
presenc
merscov
infect
camel
includ
review
found
addit
countri
bangladesh
burkina
faso
egypt
ethiopia
iraq
israel
jordan
kenya
ksa
mali
morocco
nigeria
oman
pakistan
qatar
spain
tunisia
uae
fig
addit
prome
mail
report
virusposit
camel
found
kuwait
iran
latter
reportedli
import
anim
archiv
number
countri
serolog
find
complement
find
viral
rna
dromedari
camel
burkina
faso
egypt
ethiopia
iraq
jordan
ksa
morocco
nigeria
oman
qatar
uae
investig
merscov
circul
amongst
dromedari
camel
australia
japan
kazakhstan
usa
canada
find
proof
merscov
circul
countri
merscov
circul
camel
popul
except
spain
canari
island
pakistan
bangladesh
locat
middl
east
africa
one
camel
merscov
antibodi
bangladesh
born
bangladesh
other
import
india
howev
addit
report
merscov
camel
india
record
foreign
origin
seroposit
camel
pakistan
moreov
previou
studi
alreadi
evid
seroposit
camel
origin
pakistan
combin
serolog
data
paper
includ
review
overal
median
seropreval
camel
africa
rang
compar
median
seropreval
rang
camel
middl
east
base
viral
shed
studi
african
countri
median
rate
viral
shed
rang
compar
camel
middl
east
rang
seropreval
merscov
antibodi
increas
age
camel
fraction
camel
test
posit
merscov
rna
nasal
swab
decreas
age
serolog
result
paper
includ
suffici
age
inform
combin
median
seropreval
camel
age
year
rang
age
group
year
rang
year
old
rang
combin
median
seropreval
virolog
studi
report
age
breakdown
median
rate
nasal
shed
year
old
camel
rang
case
compar
rang
camel
older
year
individu
studi
show
significantli
higher
seropreval
femal
camel
compar
male
other
show
opposit
find
signific
differ
similar
disagre
result
publish
presenc
merscov
rna
male
vs
femal
camel
studi
review
sex
camel
record
total
serum
sampl
femal
camel
sampl
male
camel
collect
analys
merscov
antibodi
compar
vs
nasal
swab
viral
rna
test
approxim
three
time
femal
camel
sampl
farm
male
camel
major
studi
look
merscov
preval
camel
slaughterhous
live
anim
market
quarantin
area
overal
median
seropreval
male
femal
camel
review
respect
rang
exclud
result
israel
kazakhstan
median
percentag
presenc
viral
rna
nasal
swab
male
camel
rang
compar
femal
camel
rang
review
sever
studi
camel
sampl
anim
market
quarantin
facil
seroposit
often
camel
farm
combin
serolog
laboratori
result
camel
review
suffici
background
inform
regard
sampl
locat
result
pattern
median
seropreval
rang
exclud
australia
spain
camel
farm
rang
camel
popul
sampl
market
quarantin
facil
studi
egypt
found
significantli
higher
pcr
posit
rate
camel
sampl
abattoir
quarantin
facil
result
could
confirm
paper
review
compar
differ
seropreval
viru
rnaposit
rate
nomad
vs
sedentari
camel
herd
author
find
statist
differ
two
herd
manag
type
other
found
evid
higher
seropreval
nomad
herd
one
studi
kenya
look
differ
herd
differ
level
isol
find
signific
differ
merscov
antibodi
level
studi
compar
local
camel
import
camel
suggest
import
camel
seroposit
merscov
often
although
differ
signific
two
studi
egypt
found
significantli
higher
rna
posit
rate
import
camel
east
africa
compar
domest
bred
camel
anoth
studi
execut
ksa
found
significantli
higher
number
merscov
rnaposit
result
amongst
local
camel
vs
camel
sudan
somalia
although
merscov
detect
almost
yearround
camel
studi
show
rel
higher
seropreval
viral
detect
cooler
winter
month
merscov
antibodi
detect
llama
alpaca
israel
alpaca
qatar
date
merscov
antibodi
viral
rna
detect
bactrian
camel
tabl
tabl
swine
goat
hors
includ
field
survey
review
test
neg
merscov
rna
antibodi
merscov
antibodi
detect
two
studi
sheep
egypt
qatar
although
low
number
howev
survey
investig
sheep
find
evid
merscov
infect
exposur
public
review
show
merscov
mainli
circul
dromedari
camel
popul
middl
east
part
africa
infect
dromedari
camel
africa
three
decad
antibodi
also
found
arab
camel
sera
earli
howev
merscov
discov
first
human
case
appear
probabl
due
minor
clinic
symptom
merscov
infect
camel
camel
survey
conduct
middl
east
northern
eastern
african
countri
signific
data
gap
current
still
exist
north
west
africa
countri
camel
popul
million
anim
algeria
libya
mauritania
niger
even
less
known
central
asian
region
evid
merscov
circul
camel
pakistan
bangladesh
recent
publish
data
lack
afghanistan
india
knowledg
presenc
merscov
anim
reservoir
crucial
first
step
assess
whether
merscov
could
relev
public
health
threat
region
merscov
infect
mainli
detect
calv
young
camel
research
includ
review
show
igg
posit
rate
increas
gradual
dromedari
camel
increas
age
merscov
rna
detect
rate
decreas
matern
igg
antibodi
camel
acquir
intak
colostrum
first
h
postparturit
h
antibodi
level
dam
milk
decreas
rapidli
one
studi
show
matern
antibodi
calv
peak
day
postparturit
declin
follow
month
month
half
calv
matern
neutral
antibodi
serum
longer
howev
field
studi
titr
merscovspecif
antibodi
still
low
month
age
increas
age
dromedari
calv
lower
undetect
antibodi
level
young
camel
like
explain
higher
merscov
rna
detect
rate
adult
camel
much
higher
merscov
seropreval
found
probabl
due
longlast
immun
respons
merscov
infect
multipl
reinfect
merscov
immun
steril
merscov
infect
shed
also
shown
adult
camel
merscov
antibodi
sever
articl
analys
seropreval
viru
shed
data
relat
factor
age
may
explain
differ
seropreval
merscov
rnaposit
rate
camel
sex
sampl
locat
herd
characterist
anim
origin
review
show
consider
heterogen
result
addit
comparison
studi
difficult
given
lack
standardis
studi
design
key
factor
consid
compar
studi
differ
distribut
male
femal
camel
amongst
differ
disciplin
camel
husbandri
femal
mainli
use
milk
reproduct
result
often
stay
farm
male
camel
especi
young
age
year
old
predomin
sex
slaughterhous
amongst
camel
use
transport
also
influenc
risk
profil
acquir
merscov
infect
femal
camel
closer
contact
calv
suscept
infect
shed
viru
higher
quantiti
compar
older
camel
hand
meat
transport
camel
predominantli
male
travel
lead
increas
contact
camel
camel
herd
therefor
higher
chanc
exposur
merscov
paper
review
suggest
gener
lower
infect
rate
domest
bred
camel
camel
farm
compar
import
camel
camel
anim
market
quarantin
facil
may
explain
increas
contact
rate
mix
camel
herd
lead
increas
chanc
merscov
exposur
spread
increas
merscov
circul
winter
spring
multipl
explan
firstli
winter
calv
season
lead
larger
proport
young
anim
usual
higher
number
merscov
infect
viru
excret
moreov
winter
season
major
increas
camel
human
movement
due
camel
race
competit
camel
breed
trade
movement
graze
ground
increas
chanc
viru
spread
addit
cooler
temperatur
may
facilit
coronaviru
surviv
environ
experiment
studi
llama
alpaca
shown
suscept
infect
merscov
confirm
two
paper
review
describ
serolog
posit
llama
alpaca
israel
alpaca
merscov
neutral
antibodi
qatar
experiment
set
animaltoanim
transmiss
shown
alpaca
make
possibl
risk
popul
human
infect
two
studi
review
also
found
antimerscov
antibodi
sheep
experiment
inocul
sheep
result
merscov
replic
antibodi
develop
howev
receptor
entri
receptor
merscov
present
sheep
tissu
make
possibl
viru
bind
sheep
respiratori
tract
may
explain
find
merscov
antibodi
pig
also
express
receptor
respiratori
tract
viral
replic
experiment
set
shown
pig
antibodi
merscov
rna
found
pig
field
survey
may
explain
limit
viral
shed
pig
absenc
animaltoanim
transmiss
show
dromedari
camel
present
larg
part
african
asian
contin
mer
infect
dromedari
camel
widespread
howev
human
infect
due
spillov
dromedari
camel
reservoir
report
africa
sever
explan
differ
human
case
arabian
peninsula
africa
suggest
differ
cultur
habit
camel
husbandri
preval
comorbid
detect
genet
factor
local
popul
moreov
west
african
virus
found
phylogenet
phenotyp
distinct
merscov
virus
caus
human
diseas
middl
east
increas
knowledg
anim
reservoir
merscov
need
combin
research
mer
preval
risk
factor
human
assess
true
public
health
risk
moreov
absenc
human
diseas
combin
mild
symptom
camel
caus
mer
like
neg
effect
willing
implement
intervent
costeffect
possibl
intervent
area
sinc
discoveri
merscov
dromedari
camel
identifi
anim
reservoir
human
infect
merscov
howev
exact
rout
human
primari
infect
still
unknown
moreov
scale
spread
preval
merscov
camel
reservoir
fulli
known
yet
sinc
still
lack
merscov
preval
data
countri
harbour
signific
proport
world
camel
popul
howev
knowledg
anim
reservoir
merscov
essenti
develop
intervent
control
measur
prevent
human
infect
prospect
studi
includ
repres
sampl
camel
differ
age
group
sex
within
differ
husbandri
practic
need
fulli
understand
pattern
merscov
circul
studi
import
may
give
inform
critic
control
point
intervent
reduc
circul
merscov
andor
exposur
human
author
orcid
r
sikkema
financi
support
studi
financi
support
european
commiss
programm
contract
number
http
wwwcompareeuropeeu
none
